ASCO 2024

Article collection

We are proud to present a special collection of articles for the American Society of Clinical Oncology Annual Meeting 2024. This curated selection showcases the cutting-edge advancements and novel perspectives published in journals from Elsevier's Oncology Journal Network. We invite you to explore this collection and delve deeper into the exciting advancements shaping the future of cancer research.

Annals of Oncology

• Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040 在新的选项卡/窗口中打开

• Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047] 在新的选项卡/窗口中打开

Blood Neoplasia

• Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination 在新的选项卡/窗口中打开

Cancer Epidemiology

• Risk factors for early-onset colorectal cancer: A Canadian prospective cohort study 在新的选项卡/窗口中打开

• Metformin’s role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study 在新的选项卡/窗口中打开

Cancer Letters

• Organoid: Bridging the gap between basic research and clinical practice 在新的选项卡/窗口中打开

• SPOP-mutant prostate cancer: Translating fundamental biology into patient care 在新的选项卡/窗口中打开

Cancer Pathogenesis and Therapy

• PI3K/AKT/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancer 在新的选项卡/窗口中打开

• Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus 在新的选项卡/窗口中打开

• Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005–2018) 在新的选项卡/窗口中打开

Cancer Treatment Reviews

• Waiting for the “liquid revolution” in the adjuvant treatment of colon cancer patients: a review of ongoing trials 在新的选项卡/窗口中打开

• First-line combination treatment with PARP and androgen receptor–signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United States 在新的选项卡/窗口中打开

Clinical Breast Cancer

• Unlocking the Power of the Homing Phenomenon: Why Breast Conserving Surgery Outshines Mastectomy in Overall Survival 在新的选项卡/窗口中打开

• Robotics in Screening, Diagnosis and Treatment of Breast Cancer: A Perspective View 在新的选项卡/窗口中打开

• Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics 在新的选项卡/窗口中打开

Clinical Colorectal Cancer

• Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis of Treatment Recommendations, Treatment Administered and Impact on Cancer Recurrence 在新的选项卡/窗口中打开

• Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review 在新的选项卡/窗口中打开

• A Case of Heavily Pretreated HER2+ Colorectal Liver Metastases Responsive to Hepatic Arterial Infusion Chemotherapy 在新的选项卡/窗口中打开

Clinical Genitourinary Cancer

• Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy 在新的选项卡/窗口中打开

• Cystic Pelvic Masses in Men: A Presentation of Uncommon Cases and a Literature Review 在新的选项卡/窗口中打开

• The Impact of Blue Light Cystoscopy Use Among Nonmuscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to Recurrence 在新的选项卡/窗口中打开

Clinical Lung Cancer

• Lung Cancer in Women: The Past, Present, and Future 在新的选项卡/窗口中打开

• Perioperative Immunotherapy for Non-Small Cell Lung Cancer: Practical Application of Emerging Data and New Challenges 在新的选项卡/窗口中打开

• Personalised Assessment and Rapid Intervention in Frail Patients With Lung Cancer: The Impact of an Outpatient Occupational Therapy Service 在新的选项卡/窗口中打开

Clinical Lymphoma Myeloma and Leukemia

• Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma 在新的选项卡/窗口中打开

• Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial 在新的选项卡/窗口中打开

• Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable 在新的选项卡/窗口中打开

Clinics

• Delayed diagnosis and increased mortality risk: Assessing the effects of the COVID-19 pandemic on breast cancer recurrence 在新的选项卡/窗口中打开

• Health-Related quality of life by 31-item Cervantes scale in breast cancer survivors undergoing adjuvant endocrine therapy 在新的选项卡/窗口中打开

• Prolonged survival after thoracic metastasectomy in patients with nonseminomatous testicular cancer 在新的选项卡/窗口中打开

Critical Reviews in Oncology/Hematology

• A practical algorithm for acute myeloid leukaemia diagnosis following the updated 2022 classifications 在新的选项卡/窗口中打开

• Oncogenic fusions: Targeting NTRK 在新的选项卡/窗口中打开

• Unraveling molecular signatures in rare bone tumors and navigating the cancer pathway landscapes for targeted therapeutics 在新的选项卡/窗口中打开

ESMO Gastrointestinal Oncology

• Benefits from early trial involvement in metastatic colorectal cancer: outcomes from the phase I unit at the Sarah Cannon Research Institute UK 在新的选项卡/窗口中打开

• Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status 在新的选项卡/窗口中打开

ESMO Open

• Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial 在新的选项卡/窗口中打开

• Antibody–drug conjugates are active in patients with HER2-positive breast cancer brain metastases: where do we go from here? 在新的选项卡/窗口中打开

ESMO Real World Data and Digital Oncology

• Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world data 在新的选项卡/窗口中打开

• Real-world patterns of treatment and response in metastatic renal cell carcinoma: a multicentre UK-wide review with UK Renal Oncology Collaborative (UK ROC) 在新的选项卡/窗口中打开

Gynecologic Oncology

• Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update 在新的选项卡/窗口中打开

• Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis 在新的选项卡/窗口中打开

• Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer 在新的选项卡/窗口中打开

• A personalized probabilistic approach to ovarian cancer diagnostics 在新的选项卡/窗口中打开

Gynecologic Oncology Reports

• Strategies for prevention and management of ocular events occurring with mirvetuximab soravtansine 在新的选项卡/窗口中打开

• The challenging journey of cervical cancer diagnosis and treatment at the second largest hospital in Indonesia 在新的选项卡/窗口中打开

• Quality corner: Safely using cephalosporins in almost all patients with penicillin allergies: Mini-review and suggested protocol to improve efficacy and surgical outcomes 在新的选项卡/窗口中打开

• Ovarian cancer think tank: An overview of the current status of ovarian cancer screening and recommendations for future directions 在新的选项卡/窗口中打开

Immuno-Oncology and Technology

• Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: The phase 1 TRIBE trial 在新的选项卡/窗口中打开

• Engineering approaches for innate immune-mediated tumor microenvironment remodeling 在新的选项卡/窗口中打开

Journal of Cancer Policy

• Implications of FDA’s marketing authorization of hereditary cancer testing 在新的选项卡/窗口中打开

• INDIGO: Example of inappropriate crossover and why PFS cannot be the primary outcome in gliomas 在新的选项卡/窗口中打开

Journal of the National Cancer Center

• Cancer incidence and mortality in China, 2016 在新的选项卡/窗口中打开

• Patterns and trends in esophageal cancer incidence and mortality in China: An analysis based on cancer registry data 在新的选项卡/窗口中打开

• The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy 在新的选项卡/窗口中打开

Journal of Thoracic Oncology

• Read here for the Journal of Thoracic Oncology ASCO articles. 在新的选项卡/窗口中打开

Leukemia Research

• CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123 在新的选项卡/窗口中打开

• Identification of unique molecular heterogeneity of human CD79, the signaling component of the human B cell antigen receptor (BCR), and synergistic potentiation of the CD79-targeted therapy of B cell tumors by co-targeting of CD79a and CD79b 在新的选项卡/窗口中打开

• The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms 在新的选项卡/窗口中打开

Leukemia Research Reports

• Successful anti-tumor effects with two novel bifunctional chemotherapeutic compounds that combine a LAT1 substrate with cytotoxic moieties in aggressive T-cell lymphomas 在新的选项卡/窗口中打开

• Myeloid neoplasms in inflammatory bowel disease: A case series and review of the literature 在新的选项卡/窗口中打开

• Long-term follow-up of efficacy and safety in elderly patients with chronic myeloid leukemia treated with intermittent low dose dasatinib therapy 在新的选项卡/窗口中打开

Magnetic Resonance Imaging

• Delineation of the internal iliac vein using MRI with true FISP sequence in patients with locally recurrent rectal cancer: A pilot study using CT/MRI fusion 在新的选项卡/窗口中打开

Neoplasia

• Interdisciplinary care of children with diffuse midline glioma 在新的选项卡/窗口中打开

Oral Oncology

• HER2-targeted therapies for salivary gland cancers 在新的选项卡/窗口中打开

• Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma 在新的选项卡/窗口中打开

Oral Oncology Reports

• Salivary exosomes as biomarkers for early diagnosis of oral squamous cell carcinoma 在新的选项卡/窗口中打开

Radiation Medicine and Protection

• Comparison of pencil beam and Monte Carlo calculations with ion chamber array measurements for patient-specific quality assurance 在新的选项卡/窗口中打开

• Alzheimer's disease and low-dose radiation therapy: A new hope 在新的选项卡/窗口中打开

• Expert consensus on radiotherapy combined with immunotherapy for esophageal cancer (2024 edition) 在新的选项卡/窗口中打开

Seminars in Oncology

• PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics 在新的选项卡/窗口中打开

• PARP inhibitors for prostate cancer 在新的选项卡/窗口中打开

Surgical Oncology Insight

• The effect of the pandemic on colorectal cancer in the United States: an increased disease burden 在新的选项卡/窗口中打开

• Assessing the OPRA Trial for surgical oncologists: Safety and feasibility of a total neoadjuvant therapy approach in patients with rectal cancer 在新的选项卡/窗口中打开

• Malignant Bowel Obstruction: Historical Lessons, Current Trends, and Future Directions 在新的选项卡/窗口中打开

• Implementation of the 2015 American Thyroid Association Guideline Changes Across a Health System: A Quality Improvement Opportunity 在新的选项卡/窗口中打开

The Breast

• Platinum chemotherapy for early triple-negative breast cancer 在新的选项卡/窗口中打开

• Effectiveness of hybrid digital breast tomosynthesis/digital mammography compared to digital mammography in women presenting for routine screening at Maroondah BreastScreen: Study protocol for a co-designed, non-randomised prospective trial 在新的选项卡/窗口中打开

• Diagnostic delays in breast cancer among young women: An emphasis on healthcare providers 在新的选项卡/窗口中打开

The Journal of Liquid Biopsy

• Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimens 在新的选项卡/窗口中打开

• Liquid biopsy: Cell-free DNA based analysis in breast cancer 在新的选项卡/窗口中打开

• New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insights 在新的选项卡/窗口中打开

ESMO Podcasts

Listen to the most recent podcasts from the ESMO portfolio.

🎙️ ADCs in HER2+ metastatic breast cancer brain metastases - ESMO Podcasts 在新的选项卡/窗口中打开

🎙️ Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer by ESMO Podcasts (soundcloud.com)

Oncology journal network

We’ll help you find the right home for your research – fast

Publishing your work can be time-consuming, especially if the first journal you submit to isn’t right for your research. With over 40 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters,  Elsevier’s Oncology Journal Network 在新的选项卡/窗口中打开 has the right home for your research. And with our transfer service, you’ll benefit from a smooth, simple publishing process.